Christophe Tzourio has an M.D. and a Ph.D. degrees. He was initially trained as a vascular neurologist and he served as a Chief Resident of neurology. In parallel to his clinician duties, he was trained in epidemiology and he joined National Institute for Health and Medical Research (INSERM) in 1994 as a Senior Researcher, was promoted to Director of Research in 2000, and to the First Class Director of Research in 2007. In 2005, he was named the Director of a new INSERM Research Unit U708 “Neuroepidemiology,” which has been given the highest possible performance grade (A+) by the Agency for the Evaluation of Research in 2008. Tzourio has published 147 papers in international peer-reviewed journals among which the BMJ, the Lancet, the NEJM, Archives of Internal Medicine, Annals of Neurology, and Circulation. In the field of clinical medicine, he is ranked in the top 1% by the ISI. Dr. Tzourio has a significant experience in evaluation of research. He is currently a Member of the Scientific Advisory Board of INSERM. He also participated in several scientific councils or steering committees in public and private entities (Foundation for Medical Research, Institut National de Veille Sanitaire, Ministry of Health, etc.). He is a Regular Reviewer for international grant applications (from Australia, New Zealand, Canada, Hong Kong, Chile, Netherlands, etc.) as well as for major international journals, such as JAMA, BMJ, Lancet, Circulation, Stroke, Hypertension, and Annals of Neurology. Tzourio has a special interest for the study of the consequences of blood pressure on the brain, particularly stroke and dementia. He is Co-PI of a large ongoing population-based cohort study the 3C study, which has for main aim to assess the importance of vascular factors in dementia. He is also the PI of the academic-initiated and driven ALBA trial aiming at the control of the hypertension-related microvessels damage on the brain.
Biography Updated on 28 November 2010